Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 552

1.
3.

Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.

Howell LP, Gurusinghe S, Tabnak F.

Diagn Cytopathol. 2009 Feb;37(2):103-10. doi: 10.1002/dc.20965.

PMID:
19021201
5.

Cervicovaginal smear abnormalities in sexually active adolescents. Implications for management.

Simsir A, Brooks S, Cochran L, Bourquin P, Ioffe OB.

Acta Cytol. 2002 Mar-Apr;46(2):271-6.

PMID:
11917572
7.

Atypical squamous cells of undetermined significance on cervical smears: follow-up study of an Asian screening population.

Cheung AN, Szeto EF, Ng KM, Fong KW, Yeung AC, Tsun OK, Khoo US, Chan KY, Ng AW.

Cancer. 2004 Apr 25;102(2):74-80.

8.
12.
13.

DNA cytometry confirms the utility of the Bethesda system for the classification of Papanicolaou smears.

Bollmann R, Bollmann M, Henson DE, Bodo M.

Cancer. 2001 Jun 25;93(3):222-8.

PMID:
11391611
15.

Does the interval between papanicolaou tests influence the quality of cytology?

Jeronimo J, Khan MJ, Schiffman M, Solomon D; ALTS Group..

Cancer. 2005 Jun 25;105(3):133-8.

16.

Opportunistic testing of medically underserved women for cervical cancer in South Africa.

van Bogaert LJ, Knapp DC.

Acta Cytol. 2001 May-Jun;45(3):313-6.

PMID:
11393060
17.
18.
19.

Screening for cervical disease in mature women: strategies for improvement.

Colgan TJ, Clarke A, Hakh N, Seidenfeld A.

Cancer. 2002 Aug 25;96(4):195-203.

20.

Supplemental Content

Support Center